GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.500 $0.720 Friday, 19th Apr 2024 ADXS stock ended at $0.572. This is 0.351% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.90% from a day low at $0.572 to a day high of $0.600.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
2021-07-08 $0.488 $0.525 $0.480 $0.494 9 890 841
2021-07-07 $0.581 $0.584 $0.495 $0.507 28 423 309
2021-07-06 $0.653 $0.710 $0.574 $0.582 135 728 853
2021-07-02 $0.485 $0.485 $0.450 $0.472 2 615 950
2021-07-01 $0.485 $0.488 $0.470 $0.478 3 042 503
2021-06-30 $0.480 $0.482 $0.461 $0.464 3 430 369
2021-06-29 $0.490 $0.497 $0.471 $0.481 2 765 124
2021-06-28 $0.489 $0.490 $0.475 $0.487 2 931 544
2021-06-25 $0.497 $0.500 $0.481 $0.489 2 195 256
2021-06-24 $0.480 $0.498 $0.471 $0.495 3 206 550
2021-06-23 $0.468 $0.500 $0.465 $0.485 6 061 379
2021-06-22 $0.449 $0.464 $0.433 $0.464 3 147 598
2021-06-21 $0.460 $0.464 $0.422 $0.452 6 007 522
2021-06-18 $0.480 $0.482 $0.456 $0.461 4 930 154
2021-06-17 $0.480 $0.495 $0.472 $0.490 4 380 127
2021-06-16 $0.493 $0.500 $0.470 $0.486 4 870 757
2021-06-15 $0.501 $0.520 $0.495 $0.499 4 326 328
2021-06-14 $0.516 $0.516 $0.493 $0.500 5 026 001
2021-06-11 $0.517 $0.538 $0.506 $0.516 4 381 377
2021-06-10 $0.529 $0.548 $0.510 $0.524 5 123 295
2021-06-09 $0.520 $0.560 $0.511 $0.523 10 122 300
2021-06-08 $0.526 $0.526 $0.485 $0.510 8 565 900
2021-06-07 $0.512 $0.540 $0.493 $0.526 7 544 646
2021-06-04 $0.538 $0.540 $0.505 $0.508 5 327 877
2021-06-03 $0.504 $0.539 $0.497 $0.520 9 457 794
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT